Next-Generation Sequencing Market: Genomic Research and Precision Medicine

4 min readSep 9, 2024

As per Fortune Business Insights’ report, the next-generation sequencing Market share sector attained a worth of USD 8.30 Billion in 2023. Forecasts indicate a promising path, foreseeing a Compound Annual Growth Rate (CAGR) of 14.6% from 2023 to 2032. This trajectory will culminate in a noteworthy achievement of USD 27.55 Billion by 2032, highlighting considerable opportunities within this flourishing high-volume industry. North America dominated the market in 2023.

Request a Free Sample PDF Brochure of Next-generation Sequencing Market: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/101000

In a recent study, Fortune Business Insights presents the nitty-gritty of the global Next-generation Sequencing Market considering 2024–2032 as the stipulated timeframe. The business report highlights the drivers, restraints, opportunities, and market growth trends. Further, all the market shares associated with the market as well as the segments are expressed in terms of value and volume.

Top Companies in the Next-generation Sequencing Market:

Illumina Inc. (U.S.)
Thermo Fisher Scientific Inc. (U.S.)
F. Hoffmann-La Roche Ltd. (Switzerland)
QIAGEN (Germany)
PacBio (U.S.)
Oxford Nanopore Technologies (U.K.)
Perkin Elmer, Inc. (U.S.)
BGI (China)

The Next-generation Sequencing Market study outlines the key regions of North America, Latin America, Europe, East Asia, and Japan along with the countries contributing the most in the respective regions. The report presents detailed insights about each market player, including SWOT analysis, main market information, market share, revenue, pricing, and gross margin.

Next-generation Sequencing Market Dynamics:

Rising Adoption in Clinical Diagnostics: NGS is increasingly used for diagnosing rare diseases, hereditary disorders, and cancer, leading to improved patient outcomes and personalized treatment plans.
Advancements in Sequencing Technology and Cost Reduction: Continuous advancements in NGS platforms, coupled with decreasing sequencing costs, expand the technology’s accessibility to a wider range of research and clinical applications.
Growing Focus on Precision Medicine and Personalized Healthcare: NGS enables the identification of genetic variations associated with disease risk, drug response, and treatment outcomes, driving the shift towards personalized medicine.
Expanding Applications in Research and Drug Discovery: NGS is used extensively in genomics research, drug discovery, and development, accelerating the identification of new drug targets and biomarkers.
Data Analysis and Bioinformatics Challenges: The vast amount of data generated by NGS requires robust data analysis tools and bioinformatics expertise. Addressing these challenges is crucial for extracting meaningful insights from NGS data.

Speak to Analyst for Queries: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/101000

The insights for each vendor consist of:

Company profile
SWOT analysis
Main market information
Market share
Revenue, pricing, and gross margin

Crucial insights in the Next-generation Sequencing Market research:

Underlying macro- and microeconomic factors impacting the growth of the Next-generation Sequencing Market.
Basic overview of Next-generation Sequencing Market, including market definition, classification, and applications.
Scrutinization of each Next-generation Sequencing Market player based on mergers & acquisitions, R&D projects, and product launches.
Adoption trend of Next-generation Sequencing Market across various industries.
Important regions and countries offer lucrative opportunities to Next-generation Sequencing Market stakeholders.

Important regions covered in the Next-generation Sequencing Market report include:

North America
Europe
Asia-Pacific
Latin America
Middle East & Africa

FAQ’s

How big is the Next-generation Sequencing Market?
What factors are influencing the Next-generation Sequencing Market growth in North America?
Who are the key Next-generation Sequencing Market players?

About Us:

Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies interspersed with relevant data.

At Fortune Business Insights, we aim to highlight our clients’ most lucrative growth opportunities. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact us:

Fortune Business Insights™ Pvt.

Phone: USA:+18339092966 (Toll Free),

United Kingdom: +448085020280 (Toll Free),

APAC: +91 744 740 1245

E-mail: sales@fortunebusinessinsights.com